Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →In a retrospective multicenter cohort of 6430 RSV-associated ICU admissions among children aged 2 to 17 years, mortality was concentrated in those with complex chronic conditions, with malignant neoplasm independently associated with higher hospital mortality odds.
The study provides observational evidence that children with malignant neoplasms are a high-risk group for mortality during RSV-associated critical illness; it supports, but does not test, the hypothesis that targeted RSV prevention or earlier risk-adapted management could reduce severe outcomes in pediatric oncology populations.
In a retrospective Vietnamese cohort of 295 patients undergoing curative-intent resection for hepatocellular carcinoma, advanced TNM stage, microvascular invasion, positive margins, and Child-Pugh B status predicted poorer disease-free survival, while a derived nomogram showed modest discrimination.
The study provides evidence for postoperative recurrence-risk stratification rather than treatment efficacy; it may be inferred that identifying high-risk patients could support intensified surveillance or selection for future adjuvant-treatment studies, but no such intervention was tested.
In a single-center retrospective Peruvian cohort of 1,121 melanoma patients treated from 2010 to 2019, adolescents and young adults had different tumor characteristics and better five-year overall and event-free survival than older groups despite a relatively high frequency of stage IV disease.
The evidence supports age-associated differences in melanoma presentation and prognosis in this Latin American cohort; it suggests—but does not test—that AYA-focused primary-care detection strategies and age-informed risk assessment could enable earlier diagnosis or improve care selection.
The study reports that siRNA-mediated FOXM1 knockdown reduces malignant behaviors, glycolysis, and xenograft growth in hepatoblastoma models, with pathway-agonist rescue experiments implicating Wnt/β-catenin signaling.
The supplied evidence shows that experimental FOXM1 silencing suppresses hepatoblastoma phenotypes and glycolytic markers in cell and xenograft models; it therefore supports the inference—not yet a clinical finding—that therapeutically inhibiting FOXM1 or its associated Wnt/β-catenin–glycolysis axis could impede hepatoblastoma growth.
This case report describes a 23-year-old woman with FGFR1::ZMYM2-rearranged T-lymphoblastic lymphoma and concurrent myeloproliferative neoplasm who received a pediatric ALL regimen, progressed to AML with sequentially identified CSF3R and PTEN variants, and died approximately 10 months after diagnosis without completing allogeneic transplantation.
The case supports prompt molecular diagnosis and early transplant evaluation in suspected MLN-FGFR1; it raises, but does not establish, the hypothesis that sequential CSF3R and PTEN alterations may mark or contribute to progression and that pediatric ALL-directed chemotherapy alone is insufficient for durable disease control.
This systematic review and meta-analysis reports frequent herbal-medicine use among vulnerable populations in Cameroon, including children, while finding limited clinical evidence for most of 93 identified plant species and summarizing selected cancer-related compounds and proposed mechanisms.
Evidence in the record shows that herbal medicines are commonly used and that selected plants or compounds have some RCT and mechanistic literature; it is only an inference that these compounds could yield pediatric-cancer therapies, because no pediatric-oncology trial results, efficacy estimates, safety data, or cancer-specific population details are provided.
In a retrospective cohort of 522 patients with high-grade conventional osteosarcoma, an interpretable gradient-boosting model using 12 clinical and laboratory variables predicted early pulmonary metastasis with an AUC of 0.891 in training and 0.742 in an independent test set.
The record supports the model as a risk-stratification tool, not as a therapy; if prospectively and externally validated, it could potentially identify patients who warrant intensified pulmonary surveillance or evaluation of risk-adapted treatment strategies, while the contributions of inflammatory and coagulation markers remain associative rather than proven therapeutic targets.
In a single-center retrospective cohort of 43 patients aged 0–26 years with post-HSCT veno-occlusive disease, worsening albumin-bilirubin score seven days after diagnosis was associated with hospital mortality.
Evidence: day-7 ALBI score differentiated survivors from non-survivors and severe ALBI was associated with higher mortality odds. Inference requiring prospective validation: serial ALBI monitoring could provide a low-cost method for identifying high-risk patients who may benefit from intensified surveillance or earlier therapeutic escalation, but this study does not show that ALBI-guided management improves outcomes.
In a retrospective single-center cohort of 110 children receiving cancer therapy in India, syndromic influenza-like illness was frequent, sometimes severe or fatal, delayed chemotherapy in 30.6% of episodes, and was more likely to require inpatient management in younger children.
The study provides observational evidence that influenza-like illness is associated with substantial supportive-care burden and treatment interruption; it supports—but does not test—the hypothesis that improved respiratory diagnostics, risk-adapted infection management, and appropriate vaccination could reduce severe illness, hospitalization, and chemotherapy delays.
In a retrospective cohort of 42 pediatric patients, a model combining ¹⁸F-MFBG PET/CT SUVmax, age, and bone metastasis differentiated neuroblastoma from ganglioneuroblastoma with an AUC of 0.856, but lacked external validation.
The study provides preliminary evidence that integrating ¹⁸F-MFBG uptake with clinical factors may improve noninvasive diagnostic classification; it is an untested inference that better classification could guide treatment selection, reduce diagnostic uncertainty, or improve outcomes.
This single-center retrospective cohort of 31 patients with spinal osteoblastoma or osteoid osteoma reports improved pain and pre-existing neurological status after surgery, one local recurrence among four Enneking-inappropriate resections, and frequent use of instrumentation to preserve spinal stability.
The record provides clinical evidence that staging-guided resection with stabilization can yield favorable outcomes in spinal osteoblastoma and osteoid osteoma; it supports only the hypothesis—not a comparative conclusion—that combining Enneking and WBB staging may help balance tumor control against structural stability and reduce recurrence risk.
This community-based mixed-methods survey of 221 Indigenous adults across 11 Northwest Territories communities found low HPV and HPV-vaccine awareness, low reported vaccination among participants aged up to 26 years, and awareness differences associated with education, age, and gender.
The study provides observational evidence that limited awareness and insufficient information are barriers to HPV vaccination; it is reasonable—but not tested here—to hypothesize that culturally tailored school- and community-based education linking HPV to cancer could increase vaccine uptake and thereby strengthen long-term cancer prevention.
